1
|
Horváth Z, Paszt A, Simonka Z, Látos M, Kaizer L, Hamar S, Vörös A, Ormándi K, Fejes Z, Oláh J, Lázár G. [New trends in the surgical treatment of axilla in breast cancer]. Magy Seb 2022; 75:169-178. [PMID: 35895538 DOI: 10.1556/1046.2022.20012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Accepted: 04/04/2022] [Indexed: 06/15/2023]
Abstract
Oncosurgical treatment of breast tumors involves the removal of metastatic axillary lymph nodes. In the last 30 years, the diagnosis and treatment of axillary lymph nodes have also undergone significant changes. The introduction of sentinel lymph node biopsy in 1993 made axillary block dissection with high morbidity safely omitted in a significant proportion of patients, and similarly, the staging of breast tumors and thus oncology and complex treatment became significantly more accurate. Shortly after the introduction of sentinel lymph node biopsy, intraoperative examination of sentinel lymph nodes (e.g. imprint cytology) also appeared, which significantly reduced the number of surgeries performed in the two sessions, thereby significantly reducing patient burden and surgical costs. The results of our study indicate that axillary block dissection is required in the treatment of axilla in an ever-decreasing group of patients and this proportion will decrease further in the future, with the increasing use of alternative axillary radiotherapy. The imprint cytological examination of sentinel lymph nodes taking into account current guidelines, no longer provides demonstrable benefits and its routine use is not justified. According to the latest international recommendations, intraoperative examination of the sentinel lymph node may be indicated in connection with mastectomy (when postoperative radiotherapy is not planned) and after neoadjuvant treatment. Our results suggest that the detection of suspected lymph nodes during preoperative axillary ultrasound may predict the stage of the disease. Based on our research results confirm that in patients receiving neoadjuvant therapy, in addition to the preoperative size of the tumour (≤20 mm, P = 0.002), the preoperative size of the lymph node (≤15 mm, P = 0.04) may also be used to predict that the stage of the disease is N0-1.
Collapse
Affiliation(s)
- Zoltán Horváth
- 1 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Sebészeti Klinika, Szeged, Magyarország (tanszékvezető: Prof. Dr. Lázár György)
| | - Attila Paszt
- 1 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Sebészeti Klinika, Szeged, Magyarország (tanszékvezető: Prof. Dr. Lázár György)
| | - Zsolt Simonka
- 1 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Sebészeti Klinika, Szeged, Magyarország (tanszékvezető: Prof. Dr. Lázár György)
| | - Melinda Látos
- 1 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Sebészeti Klinika, Szeged, Magyarország (tanszékvezető: Prof. Dr. Lázár György)
| | - László Kaizer
- 2 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Pathológiai Intézet, Szeged, Magyarország (tanszékvezető: Prof. Dr. Tiszlavicz László)
| | - Sándor Hamar
- 2 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Pathológiai Intézet, Szeged, Magyarország (tanszékvezető: Prof. Dr. Tiszlavicz László)
| | - András Vörös
- 2 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Pathológiai Intézet, Szeged, Magyarország (tanszékvezető: Prof. Dr. Tiszlavicz László)
| | - Katalin Ormándi
- 3 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Radiológiai Klinika, Szeged, Magyarország (tanszékvezető: Dr. Kincses Zsigmond Tamás)
| | - Zsuzsanna Fejes
- 3 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Radiológiai Klinika, Szeged, Magyarország (tanszékvezető: Dr. Kincses Zsigmond Tamás)
| | - Judit Oláh
- 4 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Onkoterápiás Klinika, Szeged, Magyarország (tanszékvezető: Prof. Dr. Oláh Judit)
| | - György Lázár
- 1 Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar, Sebészeti Klinika, Szeged, Magyarország (tanszékvezető: Prof. Dr. Lázár György)
| |
Collapse
|
2
|
Kalincsák J, Gőcze P, Bohonyi N, Bárdos N, Koppán M, Kovács K, Toller GL, Csima M, Papp S. [Preoperative systemic treatment of locally and locoregionally advanced high-risk endometrial cancer]. Orv Hetil 2020; 161:425-433. [PMID: 32148096 DOI: 10.1556/650.2020.31614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Introduction: Endometrial cancer is the most common invasive gynecologic malignancy in developed countries. The best survival rates are expected after surgical removal, thus the aim of a complex treatment is to achieve resecability in locally and locoregionally advanced disease. Aim: The primary purpose of this study was to evaluate if the neoadjuvant systemic treatment leads to better overall survival compared to irradiation solely. Method: From January 2015 to December 2018, we enrolled 28 patients diagnosed with irresecable, locally and locoregionally advanced high-risk endometrial carcinoma. Patients were treated by neoadjuvant paclitaxel-carboplatin, then radical hysterectomy, bilateral oophorectomy and lymphadenectomy were performed. Results: After administration of 6 cycles of carboplatin-paclitaxel, the control MR test showed tumor shrinkage in all patients. Complete resection was achieved in the case of every patient. Tumor residuum in lymph nodes was verified in 4 cases by pathological evaluation. The 2-year survival and the 2-year progression-free survival rates were 65,1% and 66,1%, respectively. The median overall survival was 16,5 months. Conclusion: Neoadjuvant treatment can be an effective approach in providing the conditions for complete tumor resection, which may result in survival advantage. Despite multimodal treatment, prognosis is poor. Orv Hetil. 2020; 161(11): 425-433.
Collapse
Affiliation(s)
- Judit Kalincsák
- Általános Orvostudományi Kar, Klinikai Központ, Szülészeti és Nőgyógyászati Klinika,Pécsi TudományegyetemPécs, Édesanyák útja 17., 7628.,Dr. Baka József Diagnosztikai, Onkoradiológiai, Kutatási és Oktatási Központ,Somogy Megyei Kaposi Mór Oktató KórházKaposvár
| | - Péter Gőcze
- Általános Orvostudományi Kar, Klinikai Központ, Szülészeti és Nőgyógyászati Klinika,Pécsi TudományegyetemPécs, Édesanyák útja 17., 7628
| | - Noémi Bohonyi
- Általános Orvostudományi Kar, Klinikai Központ, Szülészeti és Nőgyógyászati Klinika,Pécsi TudományegyetemPécs, Édesanyák útja 17., 7628
| | - Nikoletta Bárdos
- Általános Orvostudományi Kar, Klinikai Központ, Szülészeti és Nőgyógyászati Klinika,Pécsi TudományegyetemPécs, Édesanyák útja 17., 7628
| | - Miklós Koppán
- Általános Orvostudományi Kar, Klinikai Központ, Szülészeti és Nőgyógyászati Klinika,Pécsi TudományegyetemPécs, Édesanyák útja 17., 7628
| | - Krisztina Kovács
- Általános Orvostudományi Kar, Klinikai Központ, Pathologiai Intézet,Pécsi TudományegyetemPécs
| | - Gábor Lénárd Toller
- Dr. Baka József Diagnosztikai, Onkoradiológiai, Kutatási és Oktatási Központ,Somogy Megyei Kaposi Mór Oktató KórházKaposvár
| | | | - Szilárd Papp
- Általános Orvostudományi Kar, Klinikai Központ, Szülészeti és Nőgyógyászati Klinika,Pécsi TudományegyetemPécs, Édesanyák útja 17., 7628
| |
Collapse
|
3
|
Kelemen D, Lőcsei Z, Papp R, Ferencz S, Vereczkei A. [Appleby procedure - an option for surgical treatment of pancreatic body tumour infiltrating the celiac axis]. Magy Seb 2018. [PMID: 29536751 DOI: 10.1556/1046.71.2018.1.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CASE PRESENTATION After neoadjuvant oncological therapy the surgical treatment of distal pancreatic tumour - infiltrating the celiac axis and the stomach - was reported. During the operation resection of the trunc, distal pancreatectomy, splenectomy, total gastrectomy, resection of the left adrenal gland and cholecystectomy were carried out. The patient's clinical course was uneventful, only transient alteration of liver functions was detected. Histological work-up revealed R1 resection, so adjuvant oncological therapy was decided. DISCUSSION Distal pancreatic tumours are frequently inoperable. Infiltration of the celiac axis was similarly considered, however there is a chance for radical operation by the resection of the trunc, when the pancreaticoduodenal arcade will provide the arterial blood supply to the liver. Based on the above case the operative technique and the relevant questions were discussed. In pancreatic tumour and arterial infiltration the preoperative chemotherapy is absolutely recommended, because there is a chance for radical surgery in case of good response.
Collapse
Affiliation(s)
- Dezső Kelemen
- Sebészeti Klinika, Pécsi Tudományegyetem 7624 Pécs, Ifjúság útja 13
| | | | - Róbert Papp
- Sebészeti Klinika, Pécsi Tudományegyetem 7624 Pécs, Ifjúság útja 13
| | - Sándor Ferencz
- Sebészeti Klinika, Pécsi Tudományegyetem 7624 Pécs, Ifjúság útja 13
| | - András Vereczkei
- Sebészeti Klinika, Pécsi Tudományegyetem 7624 Pécs, Ifjúság útja 13
| |
Collapse
|
4
|
Géczi T, Csada E, Tiszlavicz L, Lázár G, Furák J. [Changes in the clinicopathological features of surgically treated lung cancer around the millennium]. Orv Hetil 2018; 159:391-396. [PMID: 29504418 DOI: 10.1556/650.2018.30964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Lung cancer is the most common malignant tumor in Europe and Hungary. In 2010, 10 557 new cases were registered in Hungary; 80-85% of these cases were associated with smoking. AIM In our work we analyzed the data of lung cancer patients of the last 15 years retrospectively. METHOD We examined the demographic characteristics, the histological type, the stage of the lung cancer, the type of the surgical procedure used, other supplemental treatment and survival retrospectively. RESULTS Lung cancer has occurred 50 per cent more often among females in the last decade. This growth is due to the increase of adenocarcinoma cases. Thanks to the improving diagnostic modalities and the routine follow-up of oncological patients, the number of I/A cases has been doubled recently and the preoperative staging and physical condition check-up have become more accurate. Neoadjuvant treatment has been introduced, the proportion of sublobar resections has risen, the ratio of pneumonectomy and sleeve lobectomy has become equal, so many previously unresectable cases turned to be resectable and the tolerance of adjuvant therapy has also improved. Videothoracoscopic lobectomy has become an everyday practice, leading to a decrease in the operative stress on patients. CONCLUSION In spite of this development, the five-year survival has not changed significantly, staying around 50%. Orv Hetil. 2018; 159(10): 391-396.
Collapse
Affiliation(s)
- Tibor Géczi
- Sebészeti Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Semmelweis u. 8., 6720
| | - Edit Csada
- Csongrád Megyei Mellkasi Betegségek Szakkórháza Deszk
| | - László Tiszlavicz
- Patológiai Intézet, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged
| | - György Lázár
- Sebészeti Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Semmelweis u. 8., 6720
| | - József Furák
- Sebészeti Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Semmelweis u. 8., 6720
| |
Collapse
|
5
|
Banai Z, Lestár B, Berczi L, Földi J, Harkai Z, Karácsony T. [Treatment results of patients with rectum tumor in a city hospital]. Magy Seb 2017; 70:56-63. [PMID: 28294676 DOI: 10.1556/1046.70.2017.1.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Two hundred and three patients were operated on with rectal malignancy between 2007 and 2014 in our surgical department. METHODS Of these, patients who had cancer within 16 cm of the anal verge were included. 73 patients received neoadjuvant treatment and 130 patients were treated with primary resection. The specimens were graded by the Dworak and the Rödel regression score system. RESULTS We found strong response in 45 patients and pathologic complete remission in three patients. 5-years survival was compared in the two groups operated between 2007 and 2009. While the overall survival rates were just the same, we can report that response to neoadjuvant therapy is a strong predictor of disease free survival. The incidence of loco-regional recurrence was lower in patients who received neoadjuvant treatment compared to the ones who underwent primary resection. Postoperative complications, incidence of anastomotic leakage were also analysed. We did not find increase in the postoperative complications in the group of patients with neoadjuvant treatment.
Collapse
Affiliation(s)
- Zoltán Banai
- Sebészeti Osztály, Toldy Ferenc Kórház és Rendelőintézet 2700 Cegléd, Törteli út 1-3
| | - Béla Lestár
- II. Sz. Sebészeti Osztály, Magyar Honvédség Egészségügyi Központ Budapest
| | - Lajos Berczi
- Patológiai Osztály, Toldy Ferenc Kórház és Rendelőintézet Cegléd
| | - József Földi
- Sebészeti Osztály, Toldy Ferenc Kórház és Rendelőintézet 2700 Cegléd, Törteli út 1-3
| | - Zsigmond Harkai
- Sebészeti Osztály, Toldy Ferenc Kórház és Rendelőintézet 2700 Cegléd, Törteli út 1-3
| | - Tibor Karácsony
- Sebészeti Osztály, Toldy Ferenc Kórház és Rendelőintézet 2700 Cegléd, Törteli út 1-3
| |
Collapse
|
6
|
Fábián A, Bor R, Bálint A, Farkas K, Milassin Á, Rutka M, Tiszlavicz L, Nagy F, Molnár T, Szepes Z. [Neoadjuvant treatment as a limiting factor to rectal ultrasonography]. Orv Hetil 2016; 157:1193-7. [PMID: 27452069 DOI: 10.1556/650.2016.30432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Rectal ultrasonography is a basic method for staging rectal cancer. Tissue changes after neoadjuvant treatment alter the accuracy of the method. AIM The aim of the authors was to assess the accuracy of rectal ultrasonography after preoperative chemo-radiotherapy compared to the initial staging accuracy. METHOD Rectal ultrasounds performed between 2006 and 2014 were assessed retrospectively. Ultrasonographic and pathological T and N stages were compared both in case of initial staging (control group) and re-staging. RESULTS T staging was accurate in 70% in the control group and in 61% in re-staging. Rate of overstaging was 31% after neoadjuvant treatment. None of the ypT0 cases were identified. N staging accuracy was 64% in the control group and 61% in re-staging. CONCLUSIONS Neoadjuvant treatment impairs the accuracy of rectal ultrasound. The role of re-staging with rectal ultrasonography is debatable in the assessment of the efficacy of oncological treatment and surgical planning. Orv. Hetil., 2016, 157(30), 1193-1197.
Collapse
Affiliation(s)
- Anna Fábián
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - Renáta Bor
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - Anita Bálint
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - Klaudia Farkas
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - Ágnes Milassin
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - Mariann Rutka
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - László Tiszlavicz
- Patológiai Intézet, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged
| | - Ferenc Nagy
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - Tamás Molnár
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| | - Zoltán Szepes
- I. Belgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 8-10., 6720
| |
Collapse
|